AKR1B10 抗体
(Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis. [provided by RefSeq, Jul 2008].
Recommended next Filters:
您想试用我们的人工智能搜索吗？
34 results
AKR1B10
适用: 人, 小鼠, 大鼠
WB, IHC, IHC (p), ICC
宿主: 兔
Polyclonal
unconjugated
1 image
AKR1B10
适用: 人, 小鼠, 大鼠, 马, 斑马鱼, Cow, 犬, 豚鼠, 兔, Saccharomyces cerevisiae
WB
宿主: 兔
Polyclonal
unconjugated
1 image
1 reference
Latest Publications for our AKR1B10 抗体
: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." in: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).
: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).
: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." in: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).
: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." in: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).
: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." in: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." in: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).
Aliases for AKR1B10 抗体
aldo-keto reductase family 1 member B10 (AKR1B10) 抗体aldo-keto reductase family 1, member B10 (aldose reductase) (Akr1b10) 抗体
aldo-keto reductase family 1 member B10-like 2 (AKR1B10L2) 抗体
aldo-keto reductase family 1 member B10 (Akr1b10) 抗体
aldo-keto reductase family 1 member B10 (LOC100585902) 抗体
aldo-keto reductase family 1 member B10 (LOC100723118) 抗体
aldo-keto reductase family 1 member B10 (LOC101107697) 抗体
2310005E10Rik 抗体
AKR 抗体
AKR1B10 抗体
Akr1b10 抗体
AKR1B11 抗体
AKR1B12 抗体
Akr1b16 抗体
ALDRLn 抗体
ARL-1 抗体
ARL1 抗体
HIS 抗体
HSI 抗体
您还需要查找其他产品吗？
You are here:
